Daily phosphodiesterase type 5 inhibitors plus acetylsalicylic acid improve curvature progression and pain intensity during the active phase of peyronie’s disease
Year: 2025
Type: article
Study design: Observational Study
Source: Urologia Journal
Authors: Lucio Dell’Atti, Viktoria Slyusar
Institution: Azienda Ospedaliero-Universitaria delle Marche
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410717501
